Qual é o preço para RepliCel Life Sciences Inc. (RP)

O preço para RepliCel Life Sciences Inc. (RP) é $0.01100905

Qual é a capitalização de mercado para RepliCel Life Sciences Inc. (RP)

A capitalização de mercado para RepliCel Life Sciences Inc. (RP) é $810.02K

RepliCel Life Sciences Inc. (RP) Preço e Capitalização de Mercado

Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.

Preço para RP	Ativo B	Capitalização de mercado de B	Resultados
$74,159.69 $810.02K	NVDA	$5.457T	+673,624,491.71%
$60,923.87 $810.02K	AAPL	$4.483T	+553,397,813.77%
$56,528.14 $810.02K	GOOG	$4.159T	+513,469,519.01%
$50,039.69 $810.02K	MSFT	$3.682T	+454,532,097.99%
$38,473.35 $810.02K	AMZN	$2.831T	+349,470,027.38%

Preço para RP

Ativo B

Capitalização de mercado de B

Resultados

$74,159.69 $810.02K